EVOFEM BIOSCIENCES INC's ticker is EVFM and the CUSIP is 30048L104. A total of 53 filers reported holding EVOFEM BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,243,000 | -73.3% | 1,100,000 | -58.6% | 0.07% | -75.5% |
| Q1 2021 | $4,647,000 | -25.0% | 2,655,400 | +3.2% | 0.29% | -33.6% |
| Q4 2020 | $6,198,000 | +13.2% | 2,571,900 | +10.9% | 0.44% | -6.9% |
| Q3 2020 | $5,474,000 | +29.0% | 2,319,650 | +54.6% | 0.48% | +25.9% |
| Q2 2020 | $4,245,000 | -11.3% | 1,500,000 | +66.7% | 0.38% | -26.2% |
| Q1 2020 | $4,788,000 | -13.8% | 900,000 | 0.0% | 0.51% | +25.2% |
| Q4 2019 | $5,553,000 | +22.4% | 900,000 | 0.0% | 0.41% | +18.2% |
| Q3 2019 | $4,536,000 | -19.6% | 900,000 | +5.9% | 0.35% | -16.6% |
| Q2 2019 | $5,644,000 | +95.4% | 850,000 | +3.0% | 0.42% | +93.9% |
| Q1 2019 | $2,888,000 | -10.9% | 825,000 | +6.7% | 0.21% | -20.1% |
| Q4 2018 | $3,240,000 | +145.6% | 773,300 | +137.5% | 0.27% | +204.5% |
| Q3 2018 | $1,319,000 | – | 325,570 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Taylor Wealth Management Partners | 545,413 | $954,000 | 0.35% |
| HEARTLAND ADVISORS INC | 2,655,400 | $4,647,000 | 0.29% |
| Maven Securities LTD | 2,750,000 | $4,826,000 | 0.22% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 150,000 | $263,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 265,286 | $464,000 | 0.08% |
| GREAT LAKES ADVISORS, LLC | 1,697,052 | $2,970,000 | 0.05% |
| CAAS CAPITAL MANAGEMENT LP | 2,335,305 | $4,087,000 | 0.04% |
| Virtu Financial LLC | 174,447 | $305,000 | 0.02% |
| Game Plan Financial Advisors, LLC | 18,500 | $33,000 | 0.02% |
| Baker Brothers Advisors | 2,697,110 | $4,720,000 | 0.02% |